Thu Dec 19 14:20:00 UTC 2024: **Hims & Hers Health Stock Gaps Up on Positive Analyst Reports and Strong Earnings**

NEW YORK, NY – Hims & Hers Health, Inc. (NYSE: HIMS) saw its stock price jump Tuesday, opening at $32.20 after closing at $31.25 the previous day. Trading volume was high, with 3,528,936 shares exchanged. The surge follows a series of positive analyst reports and the company’s exceeding expectations in its latest quarterly earnings announcement.

The company reported earnings per share (EPS) of $0.32 for the quarter ending November 4th, significantly surpassing analyst estimates of $0.06. Revenue reached $401.56 million, also exceeding expectations of $382.20 million, representing a 77.1% year-over-year increase. This strong performance led to a net margin of 8.19% and a return on equity of 10.97%.

Analyst sentiment is mixed but generally positive. While one analyst holds a sell rating, eight have a hold rating and eight have a buy rating. Morgan Stanley initiated coverage with an overweight rating and a $42.00 price target. Canaccord Genuity Group raised its price target to $38.00 (from $28.00), maintaining a buy rating. Other firms, however, offer more conservative assessments, with price targets ranging from $21.00 to $28.00. MarketBeat.com aggregates these ratings to an overall “Hold” rating with an average price target of $22.80.

Despite the positive momentum, insider selling remains a concern. CFO Oluyemi Okupe and CEO Andrew Dudum both sold significant shares of company stock in September, triggering a total insider sell-off of 1,064,976 shares valued at $25,396,895 over the last quarter.

Institutional investors continue to show interest in Hims & Hers Health, with several increasing their holdings significantly in recent quarters. This includes Renaissance Technologies LLC, Wellington Management Group LLP, Geode Capital Management LLC, Healthcare of Ontario Pension Plan Trust Fund, and the State of Michigan Retirement System. Currently, institutional investors own 63.52% of the company’s stock.

Hims & Hers Health operates a telehealth platform providing prescription and non-prescription health and wellness products and services. The company has a market capitalization of $6.80 billion, a P/E ratio of 70.09, and a beta of 1.25.

Read More